<DOC>
	<DOCNO>NCT02364934</DOCNO>
	<brief_summary>To explore compare effect propoful , sevoflurane , combination pharmacokinetics pharmacodynamics rocuronium . To discover confirm sex difference pharmacokinetics pharmacodynamics rocuronium . To evaluate examine age people pharmacokinetics pharmacodynamics rocuronium .</brief_summary>
	<brief_title>Pharmacokinetics Pharmacodynamics Rocuronium Closed－Loop Infusion System</brief_title>
	<detailed_description>Rocuronium non-depolarizing neuromuscular blocking agent intermediate duration action without significant cumulative property , suitable continuous infusion . This study design determine dose requirement rocuronium , administer continuous infusion maintain stable 90-99 % T1 depression ( depression first twitch train-of-four , TOF ) adult , elderly different sex patient sufentanil propoful , sevoflurane , propoful + sevoflurane anaesthesia . Methods Two hundred ten patient , ASA physical status group I II undergo elective surgical procedure study . Pateients neuromuscular metabolic disease , morbid obesity receive medication know influence neuromuscular transmission exclude study . Anaesthesia Patients assign random receive propofuol , sevolurane propoful+sevoflurane anaesthesia . All patient induce midazolam , 0.1 mg/kg , sufentnail , 0.5 μg/kg , etomidate , 0.3 mg/kg rocuronium , 0.6 mg/kg . In propoful group , anaesthesia continue propoful sufentanil . The doseage propotul sufentanil adjust blood pressure heart rate patient . In sevoflurane group , anaesthesia continue sevoflurane ( 2 % ) sufentanil . The doseage sufentanil adjust blood pressure heart rate patient . The doseage propoful sufentanil adjust blood pressure heart rate patient . Heart rate , invasive blood pressure , pulse core body temperature monitor throughout procedure . The core body temperature main tained 36°C 37°C use warm blanket . Positive pressure ventilation use maintain end-tidal CO2 4.5 kPa 5.5 kPa . The inspired end-tidal concentration carbon dioxide volatile anaesthestics monitor multigas monitor . Neuromuscular transmission monitor record electromyographic ( EMG ) activity adductor pollicis muscle result supra- maximal stimulation ulnar nerve train-of- four ( TOF ) , 2 Hz 2 , apply 10-s interval . The ulnar nerve stimulate surface electrode applied wrist , use square-wave current 0.2 ms duration . Ten minute allow stabilization anaesthesia EMG trace intubate dose rocuronium , 0.6 mg/kg , give anaesthesiologist . Rocuronium infusion A personal computer , work closed-loop system Relaxograph syringe infusion pump use administer rocuronium rate necessary stable 90-99 % block first twitch response ( 1 % &lt; T1 &lt; 10 % ) . The infusion rocuronium start automatically T1 return 5 % control value . The initial infusion rate set 10 mg/kg/min , subsequently adjust computer . Every 10 computer receive data ( T1 value ) Relaxograph . If T1 increase 10 % , infusion rate increase 2/3 . If T1 increase 15 % , bolus dose ( 0.06 mg/kg ) administer automatically avoid undesirable return muscle strength surgery . The neuromuscular block consider stable T1 change 2 % 10-min observation period . The rocuronium infusion automatically stop three consecutive T1 value equal 0 . The work mode ( automatic manual ) , last six T1 value 15-min T1 trend could observe screen . The anaesthesiologist could override computer-set infusion rate time , change work mode automatic manual , stop infusion surgery complete . All neuromuscular transmission data , well data infusion rate closed-loop system feed-back infusion relaxant , save Microsoft Excel compatible computer file .</detailed_description>
	<mesh_term>Anesthetics</mesh_term>
	<mesh_term>Propofol</mesh_term>
	<mesh_term>Sevoflurane</mesh_term>
	<mesh_term>Rocuronium</mesh_term>
	<criteria>ASA physical status group I II elective surgical procedure The subject give write informed consent participate Coronary heart disease , bronchial asthma , cardiac , lung , hepatic renal insufficiency Severe HBP , obesity ( BMI &gt; 30 ) Neuromuscular metabolic disease Receiving medication know influence neuromuscular transmission Pregnancy , psychiatric disease Allergy history Inability understand Study Information Sheet provide write consent take part study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>rocuronium</keyword>
	<keyword>sex</keyword>
	<keyword>elderly</keyword>
	<keyword>Close-loop infusion system</keyword>
</DOC>